{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:51:25Z","timestamp":1792029085363,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Institute for Pancreatic Cancer Research","award":["0004852948"],"award-info":[{"award-number":["0004852948"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1245\/s10434-021-09853-8","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T21:02:33Z","timestamp":1616878953000},"page":"4216-4224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Assessment of the Long-Term Impact of Pancreatoduodenectomy on Health-Related Quality of Life Using the EORTC QLQ-PAN26 Module"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-413X","authenticated-orcid":false,"given":"Zhi Ven","family":"Fong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Sekigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motaz","family":"Qadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fernandez-del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Warshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lillemoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,27]]},"reference":[{"issue":"3 Suppl 1","key":"9853_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.surg.2012.05.033","volume":"152","author":"NP Valsangkar","year":"2012","unstructured":"Valsangkar NP, Morales-Oyarvide V, Thayer SP, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152(3 Suppl 1):S4\u201312.","journal-title":"Surgery"},{"issue":"6","key":"9853_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2013.01.073","volume":"144","author":"JJ Farrell","year":"2013","unstructured":"Farrell JJ, Fernandez-del CC. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144(6):1303\u201315.","journal-title":"Gastroenterology"},{"issue":"1","key":"9853_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","volume":"261","author":"CR Ferrone","year":"2015","unstructured":"Ferrone CR, Marchegiani G, Hong TS, et al. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg. 2015;261(1):12\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"9853_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/SLA.0000000000002600","volume":"269","author":"T Michelakos","year":"2019","unstructured":"Michelakos T, Pergolini I, Castillo CF, et al. Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment With FOLFIRINOX. Ann Surg. 2019;269(4):733\u201340.","journal-title":"Ann Surg"},{"issue":"34","key":"9853_CR5","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1200\/JCO.2011.36.5742","volume":"29","author":"DD Von Hoff","year":"2011","unstructured":"Von Hoff DD, Ramanathan RK, Borad MJ, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I\/II trial. J Clin Oncol. 2011;29(34):4548\u201354.","journal-title":"J Clin Oncol"},{"issue":"3","key":"9853_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/SLA.0000000000003468","volume":"270","author":"FI Macedo","year":"2019","unstructured":"Macedo FI, Ryon E, Maithel SK, et al. Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine\/nab-paclitaxel chemotherapy in resected pancreatic cancer. Ann Surg. 2019;270(3):400\u201313.","journal-title":"Ann Surg"},{"issue":"9","key":"9853_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/bjs.5371","volume":"93","author":"B Schniewind","year":"2006","unstructured":"Schniewind B, Bestmann B, Henne-Bruns D, et al. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg. 2006;93(9):1099\u2013107.","journal-title":"Br J Surg"},{"issue":"6","key":"9853_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/00000658-200006000-00014","volume":"231","author":"JJ Huang","year":"2000","unstructured":"Huang JJ, Yeo CJ, Sohn TA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 2000;231(6):890\u20138.","journal-title":"Ann Surg"},{"issue":"4","key":"9853_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/SLA.0000000000002380","volume":"266","author":"ZV Fong","year":"2017","unstructured":"Fong ZV, Alvino DM, Castillo CF, et al. Health-related quality of life and functional outcomes in 5-year survivors after pancreaticoduodenectomy. Ann Surg. 2017;266(4):685\u201392.","journal-title":"Ann Surg"},{"issue":"4","key":"9853_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/SLA.0000000000002962","volume":"268","author":"CJ Allen","year":"2018","unstructured":"Allen CJ, Yakoub D, Macedo FI, et al. Long-term quality of life and gastrointestinal functional outcomes after pancreaticoduodenectomy. Ann Surg. 2018;268(4):657\u201364.","journal-title":"Ann Surg"},{"issue":"6","key":"9853_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0959-8049(99)00047-7","volume":"35","author":"D Fitzsimmons","year":"1999","unstructured":"Fitzsimmons D, Johnson CD, George S, et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer. 1999;35(6):939\u201341.","journal-title":"Eur J Cancer"},{"issue":"1","key":"9853_CR12","first-page":"19","volume":"18","author":"AAKP Eaton","year":"2017","unstructured":"Eaton AAKP, Johnson CD, et al. Psychometric validation of the EORTC QLQ-PAN26 pancreatic cancer module for assessing health related quality of life after pancreatic resection. Pancreas. 2017;18(1):19\u201325.","journal-title":"Pancreas"},{"issue":"7","key":"9853_CR13","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1245\/s10434-015-5077-z","volume":"23","author":"AA Eaton","year":"2016","unstructured":"Eaton AA, Gonen M, Karanicolas P, et al. Health-related quality of life after pancreatectomy: results from a randomized controlled trial. Ann Surg Oncol. 2016;23(7):2137\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9853_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139\u201344.","journal-title":"J Clin Oncol"},{"issue":"4","key":"9853_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archsurg.136.4.391","volume":"136","author":"JH Balcom","year":"2001","unstructured":"Balcom JH, Rattner DW, Warshaw AL, et al. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136(4):391\u20138.","journal-title":"Arch Surg"},{"key":"9853_CR16","doi-asserted-by":"crossref","unstructured":"Winter JM, Cameron JL, Lillemoe KD, et al. (2006) Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg 243(5):673\u201380; discussion 680-3.","DOI":"10.1097\/01.sla.0000216763.27673.97"},{"issue":"1","key":"9853_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000002633","volume":"270","author":"LB van Rijssen","year":"2019","unstructured":"van Rijssen LB, Gerritsen A, Henselmans I, et al. Core set of patient-reported outcomes in pancreatic cancer (COPRAC): an international delphi study among patients and health care providers. Ann Surg. 2019;270(1):158\u201364.","journal-title":"Ann Surg"},{"issue":"2","key":"9853_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.hpb.2017.09.003","volume":"20","author":"HD Heerkens","year":"2018","unstructured":"Heerkens HD, van Berkel L, Tseng DSJ, et al. Long-term health-related quality of life after pancreatic resection for malignancy in patients with and without severe postoperative complications. HPB (Oxford). 2018;20(2):188\u201395.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"9853_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2012.03.003","volume":"85","author":"M Short","year":"2013","unstructured":"Short M, Goldstein D, Halkett G, et al. Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy\/5-fluorouracil on quality of life of patients managed for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013;85(1):157\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"9853_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijrobp.2014.05.053","volume":"90","author":"PE Serrano","year":"2014","unstructured":"Serrano PE, Herman JM, Griffith KA, et al. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2014;90(2):270\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"9853_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5539\/gjhs.v8n6p203","volume":"8","author":"M Arvaniti","year":"2015","unstructured":"Arvaniti M, Danias N, Theodosopoulou E, et al. Quality of life variables assessment, before and after pancreatoduodenectomy (PD): prospective study. Glob J Health Sci. 2015;8(6):203\u201310.","journal-title":"Glob J Health Sci"},{"issue":"7","key":"9853_CR22","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.19082\/7054","volume":"10","author":"M Arvaniti","year":"2018","unstructured":"Arvaniti M, Danias N, Igoumenidis M, et al. Comparison of quality of life before and after pancreaticoduodenectomy: a prospective study. Electron Physician. 2018;10(7):7054\u201362.","journal-title":"Electron Physician"},{"issue":"2","key":"9853_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jso.24499","volume":"115","author":"JM Cloyd","year":"2017","unstructured":"Cloyd JM, Tran Cao HS, Petzel MQ, et al. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017;115(2):144\u201350.","journal-title":"J Surg Oncol"},{"issue":"1","key":"9853_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1477-2574.2011.00396.x","volume":"14","author":"L Rashid","year":"2012","unstructured":"Rashid L, Velanovich V. Symptomatic change and gastrointestinal quality of life after pancreatectomy. HPB (Oxford). 2012;14(1):9\u201313.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"9853_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hpb.2015.11.003","volume":"18","author":"PW Lim","year":"2016","unstructured":"Lim PW, Dinh KH, Sullivan M, et al. Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB (Oxford). 2016;18(4):360\u20136.","journal-title":"HPB (Oxford)"},{"issue":"55","key":"9853_CR26","doi-asserted-by":"publisher","first-page":"94920","DOI":"10.18632\/oncotarget.21659","volume":"8","author":"C Gan","year":"2017","unstructured":"Gan C, Chen YH, Liu L, et al. Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis. Oncotarget. 2017;8(55):94920\u201331.","journal-title":"Oncotarget"},{"key":"9853_CR27","first-page":"117822421882527","volume":"12","author":"A Landers","year":"2019","unstructured":"Landers A, Brown H, Strother M. The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study. Palliat Care. 2019;12:1178224218825270.","journal-title":"Palliat Care"},{"issue":"1","key":"9853_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11605-017-3564-1","volume":"22","author":"PM Puri","year":"2018","unstructured":"Puri PM, Watkins AA, Kent TS, et al. Decision-making for the management of cystic lesions of the pancreas: how satisfied are patients with surgery? J Gastrointest Surg. 2018;22(1):88\u201397.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"9853_CR29","first-page":"19","volume":"18","author":"AA Eaton","year":"2017","unstructured":"Eaton AA, Karanicolas P, Johnson CD, et al. Psychometric validation of the EORTC QLQ-PAN26 pancreatic cancer module for assessing health related quality of life after pancreatic resection. J Pancreas. 2017;18(1):19\u201325.","journal-title":"J Pancreas"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09853-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T16:21:37Z","timestamp":1625242897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09853-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,27]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9853"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09853-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,27]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}